News and Announcements
Caldera Health Appoints Robert Mitchell to CEO Role
- Published April 15, 2016 1:33PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
14th April 2016
Caldera Health has appointed Rob Mitchell to the role of Chief Executive Officer to manage overall operations of the Company and to drive commercialisation of its gene-based prostate cancer diagnostic tests.
New Zealand-born, Rob is a highly experienced senior executive, with over 30 years in leadership roles for major global international pharmaceutical businesses. He has started and built commercial operations in Asia Pacific (New Zealand, Australia, India, Hong Kong), and headed global product strategy for Roche and The Medicines Company.
His most recent experience includes ongoing product development, approval and launches in infectious disease care with the Medicines.
His most recent experience includes ongoing product development, approval and launches in infectious disease care with the Medicines Company (2011 – 15). He served initially as Senior Vice President, Head of Asia Pacific, based in Auckland, then as Senior Vice President, Global Innovation Group Leader – Infectious Disease, based in New Jersey. Before that he spent eighteen years with Roche, starting in sales and marketing in New Zealand and Australia, then holding successive positions as Managing Director of Roche Products (NZ), General Manager, Roche Thailand and Head of Global Product Strategy, Virology for F Hoffman La Roche in California.
To download the full article, please click on the link below.